GASTROESOPHAGEAL REFLUX DISEASE – IS THE MODERN TREATMENT STANDARTS SUFFICIENT TO SOLVE THE PROBLEM?
Treatment of gastroesophageal refl ux disease (GERD) as one of the most common diseases of the digestive system consists of drugs that block acid secretion (proton pump ihibitors, H2-receptor antagonists), antacids and prokinetic. Treatment is long-term and in cases of resistance requires surgery. Ta...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Shevchenko Scientific Society
2017-06-01
|
| Series: | Праці Наукового товариства імені Шевченка. Медичні науки |
| Subjects: | |
| Online Access: | https://mspsss.org.ua/index.php/journal/article/view/87 |
| Summary: | Treatment of gastroesophageal refl ux disease (GERD) as one of the most common diseases of the digestive system consists of drugs that block acid secretion (proton pump ihibitors, H2-receptor antagonists), antacids and prokinetic. Treatment is long-term and in cases of resistance requires surgery. Taking into account that the major pathogenetic mechanisms of GERD is retroperystalsis and lower diaphragmatic sphincter weakness, which can be considered as symptomatic therapy, because its main effect is aimed at blocking acid production. Pathogenic approach it’s need to establish the cause of esophageal-cardial motility disorders. Most of these disorders develop due to spinal pathologies and chronic diseases of duodenal-biliary zone. Introduction of pathogenetic therapy of GERD in combination with standard medication increase the effi ciency of this pathology treatment. |
|---|---|
| ISSN: | 2708-8634 2708-8642 |